{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:20:30Z","timestamp":1788351630777,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100024743","name":"Suez Canal University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100024743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    ESBL-producing bacteria are a problem in patients with cancer. The emergence of XDR phenotypes with ESBLs increases mortality. We aimed to evaluate ESBL-producing bacteria, the prevalence of MDR and XDR phenotypes, ESBL genes, and mortality predictors in patients with cancer in the ICU. Different clinical cultures were collected from patients in oncology ICUs. We used the VITEK2 system to identify isolates and assess antibiotic sensitivity, and the combination disk method to detect ESBL phenotypes. \u03b2-lactamase, ESBL, and carbapenem genes were detected using PCR. 136 isolates were ESBL-producing. Respiratory cultures were the main source, followed by blood cultures.\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    was the most common, followed by\n                    <jats:italic>E. coli<\/jats:italic>\n                    . Isolates showed high resistance to third- and fourth-generation cephalosporins and carbapenem antibiotics. 84.6% and 13.2% of isolates were XDR and MDR, respectively. The most harbored genes were SHV and TEM (94.1%), CTXM-15 (59.6%), SHV-12 (67.6%), and NDM (78.7%). 38.2% of isolates harbored seven \u03b2-lactamase, ESBL, and carbapenem genes.\n                    <jats:italic>K. pneumoniae<\/jats:italic>\n                    significantly harbored more ESBL and carbapenem genes than\n                    <jats:italic>E. coli<\/jats:italic>\n                    . Patient age, relapses, and hospital stay are predictors of mortality in patients. An improved surveillance program and antibiotic stewardship are urgently needed.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-67637-0","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:38:28Z","timestamp":1788349108000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extensively drug-resistant ESBL-producing enterobacterales and coexisting antimicrobial resistance genes are associated with mortality in critically ill patients with cancer"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9731-3219","authenticated-orcid":false,"given":"Samah Mohammed","family":"Refay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha Gaber","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed M.","family":"El Kazzaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"67637_CR1","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1186\/s12879-014-0647-4","volume":"14","author":"VP Chaubey","year":"2014","unstructured":"Chaubey, V. P. et al. Clinical and microbiological characteristics of bloodstream infections due to AmpC beta-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region. BMC Infect. Dis. 14, 647. https:\/\/doi.org\/10.1186\/s12879-014-0647-4 (2014).","journal-title":"BMC Infect. Dis."},{"key":"67637_CR2","doi-asserted-by":"publisher","unstructured":"Husna, A. et al. Extended-Spectrum beta-Lactamases (ESBL): Challenges and Opportunities. Biomedicines 11 https:\/\/doi.org\/10.3390\/biomedicines11112937 (2023).","DOI":"10.3390\/biomedicines11112937"},{"key":"67637_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00277-013-1698-0","volume":"92","author":"S Neumann","year":"2013","unstructured":"Neumann, S. et al. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann. Hematol. 92, 433\u2013442. https:\/\/doi.org\/10.1007\/s00277-013-1698-0 (2013).","journal-title":"Ann. Hematol."},{"key":"67637_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s11739-018-02015-x","volume":"14","author":"YJ Kim","year":"2019","unstructured":"Kim, Y. J. et al. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae infection causing septic shock in cancer patients with chemotherapy-induced febrile neutropenia. Intern. Emerg. Med. 14, 433\u2013440. https:\/\/doi.org\/10.1007\/s11739-018-02015-x (2019).","journal-title":"Intern. Emerg. Med."},{"key":"67637_CR5","doi-asserted-by":"publisher","first-page":"dlaf116","DOI":"10.1093\/jacamr\/dlaf116","volume":"7","author":"M Falcone","year":"2025","unstructured":"Falcone, M. et al. Impact of multidrug resistance in cancer patients with bloodstream infections caused by Gram-negative bacilli: results from a multicentre study. JAC Antimicrob. Resist. 7, dlaf116. https:\/\/doi.org\/10.1093\/jacamr\/dlaf116 (2025).","journal-title":"JAC Antimicrob. Resist."},{"key":"67637_CR6","doi-asserted-by":"publisher","first-page":"e0324199","DOI":"10.1371\/journal.pone.0324199","volume":"20","author":"ZG Berhe","year":"2025","unstructured":"Berhe, Z. G. et al. Magnitude of multidrug-resistant and extended-spectrum beta-lactamase-producing gram-negative bacteria from tracheal aspirates of intensive care unit patients in Ethiopia. PLoS One. 20, e0324199. https:\/\/doi.org\/10.1371\/journal.pone.0324199 (2025).","journal-title":"PLoS One"},{"key":"67637_CR7","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1093\/jac\/dku305","volume":"69","author":"MJ Vehreschild","year":"2014","unstructured":"Vehreschild, M. J. et al. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies. J. Antimicrob. Chemother. 69, 3387\u20133392 (2014).","journal-title":"J. Antimicrob. Chemother."},{"key":"67637_CR8","doi-asserted-by":"publisher","first-page":"1322874","DOI":"10.3389\/fcimb.2023.1322874","volume":"13","author":"V Jimenez-Rojas","year":"2023","unstructured":"Jimenez-Rojas, V. et al. Gut colonization and subsequent infection of neonates caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Front. Cell. Infect. Microbiol. 13, 1322874. https:\/\/doi.org\/10.3389\/fcimb.2023.1322874 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"67637_CR9","doi-asserted-by":"publisher","unstructured":"Aksoy, F. et al. Retrospective evaluation of the incidence, clinical characteristics and outcomes of gram-negative bacterial infections in patients with hematologic malignancies. Pathogens 14 https:\/\/doi.org\/10.3390\/pathogens14121238 (2025).","DOI":"10.3390\/pathogens14121238"},{"key":"67637_CR10","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.4269\/ajtmh.25-0199","volume":"113","author":"D Nygren","year":"2025","unstructured":"Nygren, D. et al. Bloodstream Infections and Antimicrobial Resistance in The Gambia: Continuous Surveillance from a Tertiary Care Center. Am. J. Trop. Med. Hyg. 113, 1320\u20131323. https:\/\/doi.org\/10.4269\/ajtmh.25-0199 (2025).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"67637_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fmed.2019.00074","volume":"6","author":"M Bassetti","year":"2019","unstructured":"Bassetti, M., Peghin, M., Vena, A. & Giacobbe, D. R. Treatment of Infections Due to MDR Gram-Negative Bacteria. Front. Med. (Lausanne). 6, 74. https:\/\/doi.org\/10.3389\/fmed.2019.00074 (2019).","journal-title":"Front. Med. (Lausanne)"},{"key":"67637_CR12","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1093\/jac\/dkaa219","volume":"75","author":"C Colmenarejo","year":"2020","unstructured":"Colmenarejo, C. et al. Prevalence and risks factors associated with ESBL-producing faecal carriage in a single long-term-care facility in Spain: emergence of CTX-M-24- and CTX-M-27-producing Escherichia coli ST131-H30R. J. Antimicrob. Chemother. 75, 2480\u20132484. https:\/\/doi.org\/10.1093\/jac\/dkaa219 (2020).","journal-title":"J. Antimicrob. Chemother."},{"key":"67637_CR13","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1093\/cid\/ciad703","volume":"78","author":"DA Hareza","year":"2024","unstructured":"Hareza, D. A. et al. Is carbapenem therapy necessary for the treatment of non-CTX-M extended-Spectrum \u03b2-lactamase-producing enterobacterales bloodstream infections? Clin. Infect. Dis. 78, 1103\u20131110 (2024).","journal-title":"Clin. Infect. Dis."},{"key":"67637_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos, A. P. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268\u2013281 (2012).","journal-title":"Clin. Microbiol. Infect."},{"key":"67637_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli, E. et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318\u2013327. https:\/\/doi.org\/10.1016\/S1473-3099(17)30753-3 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"67637_CR16","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/s12879-020-05181-6","volume":"20","author":"AM Jiang","year":"2020","unstructured":"Jiang, A. M. et al. Nosocomial infections due to multidrug-resistant bacteria in cancer patients: a six-year retrospective study of an oncology Center in Western China. BMC Infect. Dis. 20, 452. https:\/\/doi.org\/10.1186\/s12879-020-05181-6 (2020).","journal-title":"BMC Infect. Dis."},{"key":"67637_CR17","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.2147\/JIR.S506046","volume":"18","author":"X Ma","year":"2025","unstructured":"Ma, X. et al. Predicting Drug Resistance: The Use of Novel Inflammatory Markers in Identifying ESBL-Producing Klebsiella pneumoniae. J. Inflamm. Res. 18, 2153\u20132168. https:\/\/doi.org\/10.2147\/JIR.S506046 (2025).","journal-title":"J. Inflamm. Res."},{"key":"67637_CR18","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1017\/ice.2019.5","volume":"40","author":"A Emmanuel Martinez","year":"2019","unstructured":"Emmanuel Martinez, A. et al. ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome. Infect. Control Hosp. Epidemiol. 40, 408\u2013413. https:\/\/doi.org\/10.1017\/ice.2019.5 (2019).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"67637_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s41182-025-00811-8","volume":"53","author":"B Kayaaslan","year":"2025","unstructured":"Kayaaslan, B. et al. Gram-negative bacterial bloodstream infections in cancer patients: a study of epidemiological trends and antibiotic susceptibility. Trop. Med. Health. 53, 131. https:\/\/doi.org\/10.1186\/s41182-025-00811-8 (2025).","journal-title":"Trop. Med. Health"},{"key":"67637_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2147\/IDR.S442646","volume":"17","author":"M Lubwama","year":"2024","unstructured":"Lubwama, M. et al. CTX-M, TEM, and SHV Genes in Escherichia coli, Klebsiella pneumoniae, and Enterobacter spp Isolated from Hematologic Cancer Patients with Bacteremia in Uganda. Infect. Drug Resist. 17, 641\u2013653. https:\/\/doi.org\/10.2147\/IDR.S442646 (2024).","journal-title":"Infect. Drug Resist."},{"key":"67637_CR21","doi-asserted-by":"publisher","first-page":"1464573","DOI":"10.3389\/fmicb.2025.1464573","volume":"16","author":"Z Liu","year":"2025","unstructured":"Liu, Z. et al. Distribution and analysis of the resistance profiles of bacteria isolated from blood cultures in the intensive care unit. Front. Microbiol. 16, 1464573. https:\/\/doi.org\/10.3389\/fmicb.2025.1464573 (2025).","journal-title":"Front. Microbiol."},{"key":"67637_CR22","doi-asserted-by":"publisher","unstructured":"Diyana, D., Tafes, B. K., Beyene, D., Teklu, D. S. & Rao, C. Prevalence of multidrug resistant and ESBL producing Enterobacteriaceae among patients with urinary tract infections in Southwest Shewa, Ethiopia. BMC Infect. Dis. 26 https:\/\/doi.org\/10.1186\/s12879-026-12982-8 (2026).","DOI":"10.1186\/s12879-026-12982-8"},{"key":"67637_CR23","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1186\/s12879-025-11474-5","volume":"25","author":"GT Kiya","year":"2025","unstructured":"Kiya, G. T. et al. Bacterial isolates and antibiotic resistance in critically ill sepsis patients at a tertiary hospital in Ethiopia. BMC Infect. Dis. 25, 1046. https:\/\/doi.org\/10.1186\/s12879-025-11474-5 (2025).","journal-title":"BMC Infect. Dis."},{"key":"67637_CR24","doi-asserted-by":"publisher","unstructured":"Amanati, A. et al. Gram-negative gut colonization in children newly diagnosed with malignancy: microbiology, antimicrobial resistance pattern, and clinical implications. Gut Pathog. 18 https:\/\/doi.org\/10.1186\/s13099-026-00812-w (2026).","DOI":"10.1186\/s13099-026-00812-w"},{"key":"67637_CR25","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3390\/biomedicines11112937","volume":"11","author":"A Husna","year":"2023","unstructured":"Husna, A. et al. Extended-spectrum \u03b2-lactamases (ESBL): challenges and opportunities. Biomedicines 11, 2937 (2023).","journal-title":"Biomedicines"},{"key":"67637_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12866-025-04572-6","volume":"26","author":"MMA Mousa","year":"2025","unstructured":"Mousa, M. M. A., Abou-Dobara, M. I., El-Zahed, M. M., El-Sherif, M. E. & Saleh, H. H. Molecular detection and ultrastructure characterization of some drug-resistant Gram-negative bacteria isolated from bladder cancer patients. BMC Microbiol. 26, 57. https:\/\/doi.org\/10.1186\/s12866-025-04572-6 (2025).","journal-title":"BMC Microbiol."},{"key":"67637_CR27","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/bacteria3040028","volume":"3","author":"M Erkihun","year":"2024","unstructured":"Erkihun, M. et al. Epidemiology and Antimicrobial Resistance Profiles of Bacterial Isolates from Clinical Specimens at Felege Hiwot Comprehensive Specialized Hospital in Ethiopia: Retrospective Study. Bacteria 3, 405\u2013421 (2024).","journal-title":"Bacteria"},{"key":"67637_CR28","doi-asserted-by":"publisher","unstructured":"Bitew, A. & Tsige, E. High prevalence of multidrug-resistant and extended-spectrum beta-lactamase-producing enterobacteriaceae: A cross-sectional study at Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia. J Trop Med 2020, 6167234. https:\/\/doi.org\/10.1155\/2020\/6167234 (2020).","DOI":"10.1155\/2020\/6167234"},{"key":"67637_CR29","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12879-021-06243-z","volume":"21","author":"A Amanati","year":"2021","unstructured":"Amanati, A. et al. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance. BMC Infect. Dis. 21, 636 (2021).","journal-title":"BMC Infect. Dis."},{"key":"67637_CR30","doi-asserted-by":"publisher","unstructured":"Pandit, R. et al. Extended-Spectrum beta-Lactamase (ESBL) genotypes among multidrug-resistant uropathogenic Escherichia coli clinical isolates from a teaching hospital of Nepal. Interdiscip. Perspect. Infect. Dis. 2020, 6525826. https:\/\/doi.org\/10.1155\/2020\/6525826 (2020).","DOI":"10.1155\/2020\/6525826"},{"key":"67637_CR31","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3389\/fmicb.2016.01374","volume":"7","author":"A Liakopoulos","year":"2016","unstructured":"Liakopoulos, A., Mevius, D. & Ceccarelli, D. A review of SHV extended-spectrum \u03b2-lactamases: neglected yet ubiquitous. Front. Microbiol. 7, 1374 (2016).","journal-title":"Front. Microbiol."},{"key":"67637_CR32","doi-asserted-by":"crossref","unstructured":"Li, Y., Kumar, S. & Zhang, L. Mechanisms of antibiotic resistance and developments in therapeutic strategies to combat Klebsiella pneumoniae infection. Infect. Drug Resist.  1107\u20131119 (2024).","DOI":"10.2147\/IDR.S453025"},{"key":"67637_CR33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13756-020-00856-w","volume":"9","author":"ES Mohamed","year":"2020","unstructured":"Mohamed, E. S., Khairy, R. M. M. & Abdelrahim, S. S. Prevalence and molecular characteristics of ESBL and AmpC beta -lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt. Antimicrob. Resist. Infect. Control. 9, 198. https:\/\/doi.org\/10.1186\/s13756-020-00856-w (2020).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"67637_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/antibiotics12010169","volume":"12","author":"DR Ibrahim","year":"2023","unstructured":"Ibrahim, D. R. et al. Multidrug-resistant ESBL-producing E. coli in clinical samples from the UK. Antibiotics 12, 169 (2023).","journal-title":"Antibiotics"},{"key":"67637_CR35","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1093\/jac\/dkx146","volume":"72","author":"ER Bevan","year":"2017","unstructured":"Bevan, E. R., Jones, A. M. & Hawkey, P. M. Global epidemiology of CTX-M \u03b2-lactamases: temporal and geographical shifts in genotype. J. Antimicrob. Chemother. 72, 2145\u20132155 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"67637_CR36","doi-asserted-by":"publisher","first-page":"dlab092","DOI":"10.1093\/jacamr\/dlab092","volume":"3","author":"M Castanheira","year":"2021","unstructured":"Castanheira, M., Simner, P. J. & Bradford, P. A. Extended-spectrum \u03b2-lactamases: an update on their characteristics, epidemiology and detection. JAC-antimicrobial Resist. 3, dlab092 (2021).","journal-title":"JAC-antimicrobial Resist."},{"key":"67637_CR37","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0732-8893(01)00266-8","volume":"40","author":"ND Hanson","year":"2001","unstructured":"Hanson, N. D., Moland, S., Pitout, J. D. & E. & Enzymatic characterization of TEM-63, a TEM-type extended spectrum beta-lactamase expressed in three different genera of Enterobacteriaceae from South Africa. Diagn. Microbiol. Infect. Dis. 40, 199\u2013201. https:\/\/doi.org\/10.1016\/s0732-8893(01)00266-8 (2001).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"67637_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fmolb.2018.00016","volume":"5","author":"T Palzkill","year":"2018","unstructured":"Palzkill, T. Structural and mechanistic basis for extended-spectrum drug-resistance mutations in altering the specificity of TEM, CTX-M, and KPC \u03b2-lactamases. Front. Mol. Biosci. 5, 16 (2018).","journal-title":"Front. Mol. Biosci."},{"key":"67637_CR39","doi-asserted-by":"publisher","first-page":"e0220265","DOI":"10.1371\/journal.pone.0220265","volume":"14","author":"IA Critchley","year":"2019","unstructured":"Critchley, I. A., Cotroneo, N., Pucci, M. J. & Mendes, R. The burden of antimicrobial resistance among urinary tract isolates of Escherichia coli in the United States in 2017. PloS one. 14, e0220265 (2019).","journal-title":"PloS one"},{"key":"67637_CR40","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1128\/AAC.03042-15","volume":"60","author":"BL de Jonge","year":"2016","unstructured":"de Jonge, B. L. et al. In vitro susceptibility to ceftazidime-avibactam of carbapenem-nonsusceptible Enterobacteriaceae isolates collected during the INFORM global surveillance study (2012 to 2014). Antimicrob. Agents Chemother. 60, 3163\u20133169 (2016).","journal-title":"Antimicrob. Agents Chemother."},{"key":"67637_CR41","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s10096-020-03839-2","volume":"39","author":"MM Tawfick","year":"2020","unstructured":"Tawfick, M. M., Alshareef, W. A., Bendary, H. A., Elmahalawy, H. & Abdulall, A. K. The emergence of carbapenemase bla(NDM) genotype among carbapenem-resistant Enterobacteriaceae isolates from Egyptian cancer patients. Eur. J. Clin. Microbiol. Infect. Dis. 39, 1251\u20131259. https:\/\/doi.org\/10.1007\/s10096-020-03839-2 (2020).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"67637_CR42","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3389\/fmicb.2020.01422","volume":"11","author":"R Lalaoui","year":"2020","unstructured":"Lalaoui, R., Javelle, E., Bakour, S., Ubeda, C. & Rolain, J. M. Infections Due to Carbapenem-Resistant Bacteria in Patients With Hematologic Malignancies. Front. Microbiol. 11, 1422. https:\/\/doi.org\/10.3389\/fmicb.2020.01422 (2020).","journal-title":"Front. Microbiol."},{"key":"67637_CR43","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13099-024-00611-1","volume":"16","author":"B Pourakbari","year":"2024","unstructured":"Pourakbari, B., Mamishi, S., Poormohammadi, S., Hosseinpour Sadeghi, R. & Mahmoudi, S. High prevalence of carbapenem resistance and clonal expansion of bla(NDM) gene in Klebsiella pneumoniae isolates in an Iranian referral pediatric hospital. Gut Pathog. 16, 17. https:\/\/doi.org\/10.1186\/s13099-024-00611-1 (2024).","journal-title":"Gut Pathog"},{"key":"67637_CR44","doi-asserted-by":"publisher","unstructured":"Madney, Y. et al. Carbapenem-resistant enterobacteriaceae (CRE) in children with cancer: The impact of rapid diagnostics and targeted colonization strategies on improving outcomes. Microorganisms 13 https:\/\/doi.org\/10.3390\/microorganisms13071627 (2025).","DOI":"10.3390\/microorganisms13071627"},{"key":"67637_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000495314","volume":"102","author":"Y Mita","year":"2019","unstructured":"Mita, Y. et al. Clinical risk factors for death caused by extended-spectrum beta-lactamase: Producing bacteria. Urol. Int. 102, 205\u2013211 (2019).","journal-title":"Urol. Int."},{"key":"67637_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijid.2018.03.022","volume":"71","author":"B Islas-Munoz","year":"2018","unstructured":"Islas-Munoz, B. et al. Bloodstream infections in cancer patients. Risk factors associated with mortality. Int. J. Infect. Dis. 71, 59\u201364. https:\/\/doi.org\/10.1016\/j.ijid.2018.03.022 (2018).","journal-title":"Int. J. Infect. Dis."},{"key":"67637_CR47","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/s40121-021-00433-7","volume":"10","author":"Y Zheng","year":"2021","unstructured":"Zheng, Y. et al. Fatal Infections Among Cancer Patients: A Population-Based Study in the United States. Infect. Dis. Ther. 10, 871\u2013895. https:\/\/doi.org\/10.1007\/s40121-021-00433-7 (2021).","journal-title":"Infect. Dis. Ther."},{"key":"67637_CR48","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S1470-2045(20)30310-7","volume":"21","author":"K Yang","year":"2020","unstructured":"Yang, K. et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 21, 904\u2013913. https:\/\/doi.org\/10.1016\/S1470-2045(20)30310-7 (2020).","journal-title":"Lancet Oncol."},{"key":"67637_CR49","unstructured":"Institute, C. A. L. S. Performance Standards for Antimicrobial Susceptibility Testing (Clinical and Laboratory Standards Institute, 2025)."},{"key":"67637_CR50","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/jac\/48.6.839","volume":"48","author":"A Chanawong","year":"2001","unstructured":"Chanawong, A., M\u2019Zali, F. H., Heritage, J., Lulitanond, A. & Hawkey, P. M. SHV-12, SHV-5, SHV-2a and VEB-1 extended-spectrum \u03b2-lactamases in Gram-negative bacteria isolated in a university hospital in Thailand. J. Antimicrob. Chemother. 48, 839\u2013852 (2001).","journal-title":"J. Antimicrob. Chemother."},{"key":"67637_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3892\/etm.2015.2851","volume":"11","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Association of antibiotic resistance with SHV-12 extended-spectrum beta-lactamase in Enterobacter cloacae. Exp. Ther. Med. 11, 269\u2013276. https:\/\/doi.org\/10.3892\/etm.2015.2851 (2016).","journal-title":"Exp. Ther. Med."},{"key":"67637_CR52","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1590\/S1517-83822008000400007","volume":"39","author":"OB Ozgumus","year":"2008","unstructured":"Ozgumus, O. B., Tosun, I., Aydin, F. & Kilic, A. O. Horizontol dissemination of TEM-and SHV-typr beta-lactamase genes-carrying resistance plasmids amongst clonical isolates of Enterobacteriaceae. Brazilian J. Microbiol. 39, 636\u2013643 (2008).","journal-title":"Brazilian J. Microbiol."},{"key":"67637_CR53","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.flm.2018.01.001","volume":"2","author":"G Rajivgandhi","year":"2018","unstructured":"Rajivgandhi, G., Maruthupandy, M., Ramachandran, G., Priyanga, M. & Manoharan, N. Detection of ESBL genes from ciprofloxacin resistant Gram negative bacteria isolated from urinary tract infections (UTIs). Front. Lab. Med. 2, 5\u201313. https:\/\/doi.org\/10.1016\/j.flm.2018.01.001 (2018).","journal-title":"Front. Lab. Med."},{"key":"67637_CR54","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1128\/jcm.01773-10","volume":"49","author":"P Nordmann","year":"2011","unstructured":"Nordmann, P., Poirel, L., Carr\u00ebr, A., Toleman, M. A. & Walsh, T. R. How To Detect NDM-1 Producers. J. Clin. Microbiol. 49, 718\u2013721. https:\/\/doi.org\/10.1128\/jcm.01773-10 (2011).","journal-title":"J. Clin. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67637-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67637-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67637-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:51:27Z","timestamp":1788349887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67637-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67637"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-67637-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"19 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the scientific research ethics committee of the Faculty of Science, Suez Canal University (SC-Sci-REC397\/2025), which approved the study. As part of the study was conducted at South Egypt Cancer Institute, institutional permission to conduct the study at the Institute was obtained from the Dean of South Egypt Cancer Institute. This study was conducted as part of the requirements for the PhD degree of the first author. Participants were recruited from the South Egypt Cancer Institute, Assiut University. All methods were carried out in accordance with the relevant guidelines, regulations, and the principles of the Declaration of Helsinki. Written informed consent was obtained from all participants before their inclusion in the study. For participants under 18 years of age, informed consent was obtained from their parents or legal guardians.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27530"}}